This project aims to integrate specialist dementia support into the entire care team using Goldilocks technology (wearable monitor). By providing real-time insights, Goldilocks will help upskill care providers, ensuring that support workers, care co-ordinators, primary care givers and loved ones can access expert guidance and insights to enhance dementia care.
A trial will be conducted with ECH in SA, embedding Goldilocks into their care model to support aged care workers with continuous, data-driven insights. In China, Qingather Biotechnology will facilitate a parallel trial, adapting the solution for local aged care providers. These trials will assess how Goldilocks can bridge the gap between specialist dementia expertise and everyday care teams, improving workforce capability and care delivery.
The University of Adelaide will provide academic rigor, ensuring that the project is underpinned by evidence-based methodologies and thorough evaluation. By combining ECH’s expertise, Goldilocks’ technology, and academic validation, this project will enable aged care providers to deliver high-quality dementia care at scale, empowering care teams to provide more effective and timely support.
"We’re incredibly excited to receive this grant from ARIIA and to bring Goldilocks smart clothing technology to Adelaide. Goldilocks has the potential to transform dementia care by turning passive monitoring into proactive support — something previous studies have shown can significantly improve outcomes. This is a big step forward for the future of aging in place and we are super excited to partner with ECH and University of Adelaide in this."
Shem, CEO of Goldilocks